These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3109066)

  • 1. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
    Vincente V; Corrales J; Miralles J; Alberca I
    Thromb Res; 1987 Mar; 45(5):695-7. PubMed ID: 3109066
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effects.
    Jacobs GE; Hulskotte EG; van Gerven JM; Zuurman L; de Kam ML; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Burggraaf J
    J Psychopharmacol; 2011 Mar; 25(3):353-60. PubMed ID: 20142306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease.
    Casonato A; Pontara E; Bertomoro A; Zucchetto A; Zerbinati A; Girolami A
    Br J Haematol; 1995 Oct; 91(2):512-3. PubMed ID: 8547104
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 10. A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteers.
    Jacobs GE; van Gerven JM; de Kam Ml; Elassaiss-Schaap J; Ruigt G; van Pelt J; Peeters BW; Peeters PA; Hulskotte EG
    J Psychopharmacol; 2011 Mar; 25(3):361-9. PubMed ID: 20147570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects.
    Marasini B; Cugno M; Bassani C; Fabrizi I; Bottasso B; Agostoni A
    Thromb Haemost; 1992 Nov; 68(5):621. PubMed ID: 1455411
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators.
    Vicente V; Estellés A; Laso J; Moraleda JM; Rivera J; Aznar J
    Thromb Res; 1993 Apr; 70(2):117-22. PubMed ID: 8322282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (indomethacin).
    Hober C; Vantyghem MC; Racadot A; Cappoen JP; Lefebvre J
    Horm Res; 1992; 37(4-5):190-5. PubMed ID: 1490662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH secretagogues and hypothalamo-pituitary-adrenal axis.
    Boscaro M; Mancini T
    J Endocrinol Invest; 2003 Mar; 26(3):190-1. PubMed ID: 12809166
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.
    Lethagen S; Harris AS; Sjörin E; Nilsson IM
    Thromb Haemost; 1987 Dec; 58(4):1033-6. PubMed ID: 3127915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor.
    Patrassi GM; Sartori MT; Casonato A; Viero ML; Pontara E; Saggiorato G; Girolami A
    Thromb Res; 1992 Jun; 66(5):517-26. PubMed ID: 1523608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
    Mannucci PM; Canciani MT; Rota L; Donovan BS
    Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.